AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Oxybutynin patch studied for overactive bladder. (Under Review by the FDA).

OB GYN News

| December 01, 2001 | Tucker, Miriam E. | COPYRIGHT 2001 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

CHICAGO--Transdermal oxybutynin effectively reduces symptoms of overactive bladder with minimal side effects, Dr. G. Willy Davila reported at the annual meeting of the American Urogynecologic Society.

Oral oxybutynin also reduces overactive bladder symptoms, but its use is limited by anticholinergic side effects. By bypassing presystemic metabolism, transdermal oxybutynin results in lower levels of the metabolite that causes unpleasant symptoms such as dry mouth, said Dr. Davila, chairman of gynecology and head of urogynecology and reconstructive pelvic surgery at the Cleveland Clinic Florida, Weston.

Watson Pharmaceuticals' new drug application for transdermal oxybutynin is currently under review by the Food and Drug Administration, In a study sponsored by that company, prompt decreases in urinary incontinence episodes occurred following initiation of oxybutynin or placebo patch in 447 subjects (92% women) who had been experiencing at least 10 urge incontinence episodes a week and at least eight normal voids per day with a mean voided volume of 350 cc or less.

Over a 12-week period, the response to 1.3 mg/day and 2.6 mg/day of ...

Related articles from newspapers, magazines, journals, and more
FDA Approves Vesicare for Treatment of Overactive Bladder; New OnceDaily...
News wire article from: Europe Intelligence Wire November 22, 2004 700+ words
...Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency...significantly reduce the number of incontinence episodes for patients during a 12-week...OAB. - Reduction in the number of incontinence episodes was also significantly greater with...
FDA Approves Vesicare for Treatment of Overactive Bladder; New Once-Daily...
News wire article from: AScribe Business & Economics News Service November 22, 2004 700+ words
...Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency...significantly reduce the number of incontinence episodes for patients during a 12-week...OAB. - Reduction in the number of incontinence episodes was also significantly greater with...
New Research Shows Well-Tolerated Tolterodine Cuts Incontinence Episodes in...
Press release article from: PR Newswire August 25, 1999 700+ words
...only reduces incontinence episodes (or wetting...percent in overactive bladder patients...improvements in incontinence episodes, frequency...therapy for overactive bladder has been limited...in reducing incontinence episodes, and offers...treatment of ...
FDA Approves Vesicare(R) (solifenacin succinate) for the Treatment of...
Press release article from: PR Newswire November 22, 2004 700+ words
...Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency...significantly reduce the number of incontinence episodes for patients during a 12-week...OAB. * Reduction in the number of incontinence episodes was also significantly greater with...
Overactive Bladder Episodes Completely Controlled in 40 Percent of Elderly...
Press release article from: PR Newswire May 20, 2000 700+ words
...suffering from overactive bladder can significantly...reported no incontinence episodes, while the...eliminating their incontinence episodes when taking...Institute. Overactive bladder is a common...429 adult overactive bladder patients with ...
ALZA Corporation Launches Direct-to-Consumer Campaign on Overactive Bladder And...
Press release article from: PR Newswire June 10, 1999 700+ words
...educating physicians about overactive bladder and the unique benefits...from the symptoms of overactive bladder to help them understand...demonstrated in 429 adult overactive bladder patients with incontinence episodes in three controlled...
Long Term Study Shows Once-a-Day Oxybutynin Improves Quality of Life For...
Press release article from: PR Newswire August 31, 2000 700+ words
...subjects with symptoms of overactive bladder. Researchers assessed...reductions in urge incontinence episodes between 83% and 90...studied in 429 adult overactive bladder patients with incontinence episodes in three controlled...
Study Evaluates Long-Term Continuation Rate With ALZA's Ditropan(R) XL As...
Press release article from: PR Newswire August 25, 1999 700+ words
...Americans suffer from overactive bladder -- a common, treatable...day treatment for overactive bladder in the United States...demonstrated in 429 adult overactive bladder patients with incontinence episodes in three controlled...
Improved overactive bladder is a side benefit of new incontinence Tx....
Magazine article from: OB GYN News February 1, 2003 700+ words
...incontinence plus an overactive bladder, and 47...criteria for overactive bladder. The median number of incontinence episodes per week...incontinence and overactive bladder: a 58...number of incontinence episodes per week...
Indevus Announces Positive Phase II Results for Sanctura XR; Trial Supports...
Press release article from: Business Wire June 15, 2005 700+ words
...XR in 148 patients with overactive bladder. The common symptoms of overactive bladder, such as urgency, frequency and incontinence episodes were measured daily...symptoms and signs of overactive bladder. The magnitude of improvement...
For more facts and information, see all results

Source: HighBeam Research, Oxybutynin patch studied for overactive bladder. (Under Review by the...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA